Eli Lilly Alzheimer’s Drug Trial Delivers 40% Slowdown in Cognitive Decline: Phase 3 Results Spark FDA Fast-Track Hopes
Eli Lilly's phase 3 trial for new Alzheimer's drug shows 40% slowdown…
Harvard Study Reveals Microplastics in Blood Tied to Cognitive Decline in US Adults
A Harvard study of 5,000 US adults links microplastics in blood to…
Daily Walking Thousands of Steps May Delay Alzheimer’s Onset, Groundbreaking Study Finds
A groundbreaking study reveals that walking thousands of steps daily can slow…
